Boyds

Conversations in Drug Development

Science EN ↓ 28 episoder

Welcome to Conversations in Drug Development, brought to you by the team at Boyds. This podcast is for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development.

Husk at besøge podcastens hjemmeside og støtte skaberen: conversationsindrugdevelopmentwithboyds.podbean.com

Forfatter

Boyds

Kategori

Science

Podcastens hjemmeside

conversationsindrugdevelopmentwithboyds.podbean.com

Seneste episode

13. okt. 2026

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Installer gratis Android næsten 10 mio. downloads · 4,7+ i bedømmelse iOS snart

Episoder

Off-the-Shelf Cell Therapies: Breaking Barriers and Revolutionizing Patient Care 04.12.2023 20:30

In this episode of "Conversations in Drug Development", Harriet Edwards and Dr. Patrick Ginty discuss off-the-shelf cell therapies, explaining how these therapies are manufactured and their ability to treat multiple recipients. While these therapies offer scalability and the potential to treat larger patient populations, they also carry risks such as immune reactions. Dr. Ginty highlights the impo...

The Future of Drug Development: AI’s Role in Revolutionizing the Industry 08.11.2023 22:13

In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence (AI) in drug development, exploring its applications in data analysis and toxicity prediction, and its potential to reduce animal testing. Join us in this conversation, as we discuss the challenges of regulating AI in this rapidly evolving field and...

Recent Trends in Oncology Drug Development 04.10.2023 25:14

In this episode, Dr Katherine Bowen and Dr Julie Warner delve deep into the ever-evolving world of oncology drug development and the regulatory landscape in the US and EU. Join us in this conversation, as we cover the key shifts in the field over the past few decades, regulatory challenges, FDA initiatives and future developments in oncology drug development, including the impact of AI, machine le...